Anti-Androgen Receptor antibody [EP670Y]
| Name | Anti-Androgen Receptor antibody [EP670Y] |
|---|---|
| Supplier | Abcam |
| Catalog | ab52615 |
| Prices | $395.00 |
| Sizes | 100 µl |
| Host | Rabbit |
| Clonality | Monoclonal |
| Isotype | IgG |
| Clone | EP670Y |
| Applications | WB FC |
| Species Reactivities | Mouse, Rat, Human |
| Antigen | Synthetic peptide corresponding to residues on the C-terminus of human Androgen Receptor |
| Blocking Peptide | Androgen Receptor peptide |
| Description | Rabbit Monoclonal |
| Gene | AR |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
![Anti-Androgen Receptor antibody [EP670Y] (ab52615) at 1/10000 dilution + LnCaP cell lysate at 10 µgSecondaryGoat anti-rabbit HRP antibody at 1/2000 dilution](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_1/6833_ab52615wb.jpg)
Anti-Androgen Receptor antibody [EP670Y] (ab52615) at 1/10000 dilution + LnCaP cell lysate at 10 µgSecondaryGoat anti-rabbit HRP antibody at 1/2000 dilution
Overlay histogram showing PC3 cells stained with ab52615 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab52615, 1/100 dilution) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22ºC. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
Product References
Role of the androgen receptor in breast cancer and preclinical analysis of - Role of the androgen receptor in breast cancer and preclinical analysis of
Cochrane DR, Bernales S, Jacobsen BM, Cittelly DM, Howe EN, D'Amato NC, Spoelstra NS, Edgerton SM, Jean A, Guerrero J, Gomez F, Medicherla S, Alfaro IE, McCullagh E, Jedlicka P, Torkko KC, Thor AD, Elias AD, Protter AA, Richer JK. Breast Cancer Res. 2014 Jan 22;16(1):R7.
Androgen receptor splice variants determine taxane sensitivity in prostate - Androgen receptor splice variants determine taxane sensitivity in prostate
Thadani-Mulero M, Portella L, Sun S, Sung M, Matov A, Vessella RL, Corey E, Nanus DM, Plymate SR, Giannakakou P. Cancer Res. 2014 Apr 15;74(8):2270-82.
PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer. - PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer.
Moon H, Lee CS, Inder KL, Sharma S, Choi E, Black DM, Le Cao KA, Winterford C, Coward JI, Ling MT, Craik DJ, Parton RG, Russell PJ, Hill MM. Oncogene. 2014 Jul 3;33(27):3561-70.
First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense - First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense
Bianchini D, Omlin A, Pezaro C, Lorente D, Ferraldeschi R, Mukherji D, Crespo M, Figueiredo I, Miranda S, Riisnaes R, Zivi A, Buchbinder A, Rathkopf DE, Attard G, Scher HI, de Bono J, Danila DC. Br J Cancer. 2013 Nov 12;109(10):2579-86.
Multipotent and unipotent progenitors contribute to prostate postnatal - Multipotent and unipotent progenitors contribute to prostate postnatal
Ousset M, Van Keymeulen A, Bouvencourt G, Sharma N, Achouri Y, Simons BD, Blanpain C. Nat Cell Biol. 2012 Nov;14(11):1131-8.
Androgen deprivation causes epithelial-mesenchymal transition in the prostate: - Androgen deprivation causes epithelial-mesenchymal transition in the prostate:
Sun Y, Wang BE, Leong KG, Yue P, Li L, Jhunjhunwala S, Chen D, Seo K, Modrusan Z, Gao WQ, Settleman J, Johnson L. Cancer Res. 2012 Jan 15;72(2):527-36.
Inhibition of glycogen synthase kinase-3beta counteracts ligand-independent - Inhibition of glycogen synthase kinase-3beta counteracts ligand-independent
Schutz SV, Schrader AJ, Zengerling F, Genze F, Cronauer MV, Schrader M. PLoS One. 2011;6(9):e25341.
Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive - Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive
Tieszen CR, Goyeneche AA, Brandhagen BN, Ortbahn CT, Telleria CM. BMC Cancer. 2011 May 27;11:207.
Androgen receptor levels and association with PIK3CA mutations and prognosis in - Androgen receptor levels and association with PIK3CA mutations and prognosis in
Gonzalez-Angulo AM, Stemke-Hale K, Palla SL, Carey M, Agarwal R, Meric-Berstam F, Traina TA, Hudis C, Hortobagyi GN, Gerald WL, Mills GB, Hennessy BT. Clin Cancer Res. 2009 Apr 1;15(7):2472-8.
An efficient chemical approach to bispecific antibodies and antibodies of high - An efficient chemical approach to bispecific antibodies and antibodies of high
Gavrilyuk JI, Wuellner U, Salahuddin S, Goswami RK, Sinha SC, Barbas CF 3rd. Bioorg Med Chem Lett. 2009 Jul 15;19(14):3716-20. doi: